Health Condition 1: - Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Cisatracurium Besylate 0.2mg/kg loading dose followed by 0.03mg/kg maintenance dose: TO assess the
ï?? Time of onset
ï?? Intubating conditions
ï?? Duration of action of loading dose
ï
Sponsors
Government medical college Baroda
Eligibility
Inclusion criteria
Inclusion criteria: • ASA I and ASA II patients • Aged from 18 to 65 years old • Either genders • Patients scheduled for surgeries performed under general anaesthesia of an anticipated duration of 1.5-2.5 hrs
Exclusion criteria
Exclusion criteria: • Patients unwilling to participate • Patients with difficult airway. • Patients with systemic disorders like hypertension, diabetes mellites, bronchial asthma, history of allergy, hepatic and renal dysfunction. • Pregnant or lactating women • Patients on medication known to interact with neuromuscular blocking drugs e.g • Antibiotics (aminoglycosides and tetracycline), • Antidepressants (Lithium) • Anticonvulsants (Phenytoin, Carbamazepine) • Antiarrhythmics (calcium channel blockers like verapamil and nifedipine; and quinidine) • Magnesium sulphate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time of onset Intubating conditions Duration of action of loading dose Total drug required Reversal characteristics Timepoint: 7 months | — |
Secondary
| Measure | Time frame |
|---|---|
| ï?? Hemodynamic effects ï?? Intra-operative and post-operative complications /side effects Timepoint: 7 months | — |
Countries
India
Contacts
Public ContactDr Swati Bhatt
Government medical college,Baroda
Outcome results
None listed